 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 1999, 19(21):9642-9653
Spinal Opioid Analgesia: How Critical Is the Regulation of
Substance P Signaling?
Jodie A.
Trafton1,
Catherine
Abbadie1,
Serge
Marchand2,
Patrick W.
Mantyh3, and
Allan I.
Basbaum1
1 Departments of Anatomy and Physiology and W. M. Keck Foundation for Integrative Neuroscience, University of California
San Francisco, San Francisco, California 94143, 2 Department of Clinical Sciences, University of Quebec,
Rouyn-Noranda, Quebec, Canada, J9X5E4, and 3 Molecular
Neurobiology Laboratory, Veterans Administration Medical Center,
Minneapolis, Minnesota 55417
Although opioids can reduce stimulus-evoked efflux of Substance P
(SP) from nociceptive primary afferents, the consequences of this
reduction on spinal cord nociceptive processing has not been studied.
Rather than assaying SP release, in the present study we examined the
effect of opioids on two postsynaptic measures of SP release, Fos
expression and neurokinin-1 (NK-1) receptor internalization, in the
rat. The functional significance of the latter was first established in
in vitro studies that showed that SP-induced
Ca2+ mobilization is highly correlated with the
magnitude of SP-induced NK-1 receptor internalization in dorsal horn
neurons. Using an in vivo analysis, we found that
morphine had little effect on noxious stimulus-evoked internalization
of the NK-1 receptor in lamina I neurons. However, internalization was
reduced when we coadministered morphine with a dose of an NK-1 receptor
antagonist that by itself was without effect. Thus, although opioids
may modulate SP release, the residual release is sufficient to exert maximal effects on the target NK-1 receptors. Morphine significantly reduced noxious stimulus-induced Fos expression in lamina I, but the
Fos inhibition was less pronounced in neurons that expressed the NK-1
receptor. Taken together, these results suggest that opioid analgesia
predominantly involves postsynaptic inhibitory mechanisms and/or
presynaptic control of non-SP-containing primary afferent nociceptors.
Key words:
morphine; dorsal horn; tachykinin; nociception; internalization; intrathecal
Copyright © 1999 Society for Neuroscience 0270-6474/99/19219642-12$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
R. H. Kline IV and R. G. Wiley
Spinal {micro}-Opioid Receptor-Expressing Dorsal Horn Neurons: Role in Nociception and Morphine Antinociception
J. Neurosci.,
January 23, 2008;
28(4):
904 - 913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Guan, J. Borzan, R. A. Meyer, and S. N. Raja
Windup in dorsal horn neurons is modulated by endogenous spinal mu-opioid mechanisms.
J. Neurosci.,
April 19, 2006;
26(16):
4298 - 4307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gu, I. Kondo, X.-Y. Hua, and T. L. Yaksh
Resting and Evoked Spinal Substance P Release during Chronic Intrathecal Morphine Infusion: Parallels with Tolerance and Dependence
J. Pharmacol. Exp. Ther.,
September 1, 2005;
314(3):
1362 - 1369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kondo, J. C. G. Marvizon, B. Song, F. Salgado, S. Codeluppi, X.-Y. Hua, and T. L. Yaksh
Inhibition by Spinal {micro}- and {delta}-Opioid Agonists of Afferent-Evoked Substance P Release
J. Neurosci.,
April 6, 2005;
25(14):
3651 - 3660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Song and J. C. G. Marvizon
Dorsal Horn Neurons Firing at High Frequency, But Not Primary Afferents, Release Opioid Peptides that Produce {micro}-Opioid Receptor Internalization in the Rat Spinal Cord
J. Neurosci.,
October 8, 2003;
23(27):
9171 - 9184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Song and J. C. G. Marvizon
Peptidases Prevent {micro}-Opioid Receptor Internalization in Dorsal Horn Neurons by Endogenously Released Opioids
J. Neurosci.,
March 1, 2003;
23(5):
1847 - 1858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Jasmin, D. Tien, D. Weinshenker, R. D. Palmiter, P. G. Green, G. Janni, and P. T. Ohara
The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline
PNAS,
January 22, 2002;
99(2):
1029 - 1034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Trafton, C. Abbadie, and A. I. Basbaum
Differential Contribution of Substance P and Neurokinin A to Spinal Cord Neurokinin-1 Receptor Signaling in the Rat
J. Neurosci.,
May 15, 2001;
21(10):
3656 - 3664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bester, C. De Felipe, and S. P. Hunt
The NK1 Receptor Is Essential for the Full Expression of Noxious Inhibitory Controls in the Mouse
J. Neurosci.,
February 1, 2001;
21(3):
1039 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Trafton, C. Abbadie, K. Marek, and A. I. Basbaum
Postsynaptic Signaling via the {micro}-Opioid Receptor: Responses of Dorsal Horn Neurons to Exogenous Opioids and Noxious Stimulation
J. Neurosci.,
December 1, 2000;
20(23):
8578 - 8584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Aicher, A. Punnoose, and A. Goldberg
{micro}-Opioid Receptors Often Colocalize with the Substance P Receptor (NK1) in the Trigeminal Dorsal Horn
J. Neurosci.,
June 1, 2000;
20(11):
4345 - 4354.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|